Biomarkers and personalised medicine for asthma

Michael Roth, Daiana Stolz

Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018

Journal Issue: January

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michael Roth, Daiana Stolz. Biomarkers and personalised medicine for asthma. Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Predictive and personalised medicine for asthma using genomics Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
The future of personalised medicine in COPD Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016
Asthma susceptibility: from pathophysiology to personalised medicine Source: International Congress 2015 – ME4 Asthma susceptibility Year: 2015
Personalised medicine in asthma: from curative to preventive medicine Source: Eur Respir Rev 2017; 26: 160010 Year: 2017
Biomarkers in respiratory medicine Source: International Congress 2014 – PG03 Respiratory medicine: diagnosis to treatment from a mentor and junior perspective Year: 2014
Biomarkers and personalised treatment Source: Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment Year: 2012
A personalised medicine approach to ICS use in COPD Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019
Personalised medicine in exacerbations of COPD: the beginnings Source: Eur Respir J 2012; 40: 1318-1319 Year: 2012
Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017
Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021
Detection of COPD in the setting of occupational medicine Source: Annual Congress 2008 - COPD epidemiology Year: 2008
In the era of personalized medicine, what are the current unmet needs in asthma? Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now? Year: 2019
The impact of personalised therapies on respiratory medicine Source: Eur Respir Rev 2013; 22: 72-74 Year: 2013
Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021
Personalised medicine through biological subphenotyping of ARDS Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment Year: 2021
From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020
Personalised medicine in paediatric asthma, including from the patient's perspective Source: International Congress 2016 – PG8 Paediatric asthma Year: 2016
Personalised medicine in asthma: time for action Source: Eur Respir Rev, 26 (145) 170064; 10.1183/16000617.0064-2017 Year: 2017